wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q48556502-C10078F7-D53A-4812-A215-10791C3B3D89
Q48556502-C10078F7-D53A-4812-A215-10791C3B3D89
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48556502-C10078F7-D53A-4812-A215-10791C3B3D89
JAK inhibition as a therapeutic strategy for immune and inflammatory diseases.
P2860
Q48556502-C10078F7-D53A-4812-A215-10791C3B3D89
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48556502-C10078F7-D53A-4812-A215-10791C3B3D89
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b82240762826256506d43cda445238560baeef06
P2860
Efficacy and safety of the oral Janus kinase inhibitor peficitinib (ASP015K) monotherapy in patients with moderate to severe rheumatoid arthritis in Japan: a 12-week, randomised, double-blind, placebo-controlled phase IIb study